DataLabs announces clinical trial software licensing agreement with Merck

"During the pilot phase, DataLabs helped the Human Health division save considerably on data management costs without significantly changing our processes," said Jim Karkanias, Executive Director of C

By Editor on Jul 10, 2003

"During the pilot phase, DataLabs helped the Human Health division save considerably on data management costs without significantly changing our processes," said Jim Karkanias, Executive Director of CDP Operations in the U.S. Human Health Division of Merck & Co., Inc. "By licensing DataLabsXC, Merck expects additional savings on future clinical studies as more effective processes are enabled by this technology."

DataLabsXC is an EDC application built with Microsoft Visual Studio .NET 2003, the .NET Framework and the Microsoft Windows Server System. The DataLabsXC software suite provides a seamless flow of information for clinical trial decisions, which reduces the total cost of drug development and delivers drugs to market faster. By taking advantage of Microsoft technologies and the CDISC ODM model for the import and export of data, DataLabsXC integrates easily with existing legacy and clinical systems.

"DataLabsXC and the Microsoft .NET Framework enabled us to integrate legacy systems with minimal additional resources and effort," said Karkanias. "With the DataLabs solution, we have achieved the lowest total cost of ownership for any electronic data capture product we have used to date."